Integrum AB Series B Total Liabilities

Latest as of June 2026: Skr24.96 Million SEK ≈ $2.69 Million USD

Integrum AB Series B total liabilities. Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr24.96 Million SEK (≈ $2.69 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Integrum AB Series B defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Integrum AB Series B (2013–2025)

Total liabilities of Integrum AB Series B from 2013 to 2025. This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data.

Integrum AB Series B Competitors by Total Liabilities

The table below lists competitors of Integrum AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
Sewoo Global Co., Ltd KO:013000	Korea	₩7.68 Billion
Global Uranium and Enrichment Ltd AU:GUE	Australia	AU$11.73 Million
Mitchells & Butlers PLC LSE:MAB	UK	GBX2.64 Billion
eMnet Inc KQ:123570	Korea	₩33.36 Billion
Pili International Multimedia Co Ltd TWO:8450	Taiwan	NT$559.52 Million
enX Group Ltd JSE:ENX	South Africa	ZAC604.02 Million
GTN Ltd AU:GTN	Australia	AU$115.94 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Integrum AB Series B's balance sheet.

Liquidity & Leverage Metrics

Integrum AB Series B Total Liabilities Ratios Explained

Integrum AB Series B total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integrum AB Series B (2013–2025)

The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr31.59 Million ≈ $3.40 Million	+24.48%
2024-12-31	Skr25.38 Million ≈ $2.73 Million	+14.98%
2023-12-31	Skr22.07 Million ≈ $2.38 Million	+2.01%
2022-12-31	Skr21.64 Million ≈ $2.33 Million	+4.55%
2021-12-31	Skr20.70 Million ≈ $2.23 Million	+60.25%
2020-12-31	Skr12.91 Million ≈ $1.39 Million	+52.49%
2019-12-31	Skr8.47 Million ≈ $911.38K	-4.33%
2018-12-31	Skr8.85 Million ≈ $952.60K	+5.65%
2017-12-31	Skr8.38 Million ≈ $901.62K	-9.31%
2016-12-31	Skr9.24 Million ≈ $994.23K	+2.27%
2015-12-31	Skr9.03 Million ≈ $972.20K	+71.03%
2014-12-31	Skr5.28 Million ≈ $568.43K	-5.99%
2013-12-31	Skr5.62 Million ≈ $604.66K	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$22.97 Million

Skr213.43 Million SEK

Market Cap Rank

#24506 Global

#479 in Sweden

Share Price

Skr8.20

Change (1 day)

-0.85%

52-Week Range

Skr6.96 - Skr11.80

All Time High

Skr102.00